{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:40:48Z","timestamp":1777588848694,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s00066-009-1968-x","type":"journal-article","created":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T10:04:00Z","timestamp":1249293840000},"page":"506-511","source":"Crossref","is-referenced-by-count":27,"title":["Radiation Therapy for Prevention of Heterotopic Ossification about the Elbow","Strahlentherapie zur Pr\u00e4vention heterotoper Ossifikationen am Ellbogengelenk"],"prefix":"10.1007","volume":"185","author":[{"given":"Reinhard","family":"Heyd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Buhleier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Zamboglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,4]]},"reference":[{"key":"1968_CR1","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1245\/s10434-008-0048-2","volume":"15","author":"F.J. Attenello","year":"2008","unstructured":"Attenello FJ, Mukherjee D, Datoo G, et al. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience. Ann Surg Oncol 2008;15:2887\u201393.","journal-title":"Ann Surg Oncol"},{"key":"1968_CR2","first-page":"29","volume":"9","author":"K.V. Ballman","year":"2007","unstructured":"Ballman KV, Buckner JC, Brown PD, et al. The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme. Neurooncology 2007;9:29\u201338.","journal-title":"Neurooncology"},{"key":"1968_CR3","first-page":"220","volume":"48","author":"M. Bartolomei","year":"2004","unstructured":"Bartolomei M, Mazzetta C, Handkiewicz-Junak D, et al. Combined treatment of glioblastoma patients with locoregional pre-targeted 90Y-biotin radioimmunotherapy and temozolomide. Q J Nucl Med Mol Imaging 2004;48:220\u20138.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"1968_CR4","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/0360-3016(94)90331-X","volume":"30","author":"M. Bernstein","year":"1994","unstructured":"Bernstein M, Laperriere N, Glen J, et al. Brachytherapy for recurrent astrocytoma. Int J Radiat Oncol Biol Phys 1994;30:1213\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1968_CR5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11060-008-9540-6","volume":"88","author":"A. Boiardi","year":"2008","unstructured":"Boiardi A, Silvani A, Eoli M, et al. Treatment of recurrent glioblastoma: can local delivery of mitoxantrone improve survival? J Neurooncol 2008;88:105\u201313.","journal-title":"J Neurooncol"},{"key":"1968_CR6","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0140-6736(95)90755-6","volume":"345","author":"H. Brem","year":"1995","unstructured":"Brem H, Piantadosi S, Burger PC, et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet 1995;345:1008\u201312.","journal-title":"Lancet"},{"key":"1968_CR7","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/1097-0142(19940815)74:4<1342::AID-CNCR2820740426>3.0.CO;2-Y","volume":"74","author":"M.C. Chamberlain","year":"1994","unstructured":"Chamberlain MC, Barba D, Kormanik P, et al. Stereotactic radiosurgery for recurrent gliomas. Cancer 1994;74:1342\u20137.","journal-title":"Cancer"},{"key":"1968_CR8","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.ijrobp.2004.12.032","volume":"62","author":"T.A. Chan","year":"2005","unstructured":"Chan TA, Weingart JD, Parisi M, et al. Treatment of recurrent glioblastoma multiforme with Gliasite brachytherapy. Int J Radiat Oncol Biol Phys 2005;62:1133\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1968_CR9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s007010170037","volume":"143","author":"F. Colombo","year":"2001","unstructured":"Colombo F, Francescon P, Cavedon C, et al. Employ of a new device for intra-operative radiotherapy of intracranial tumours. Acta Neurochir (Wien) 2001;143:827\u201331.","journal-title":"Acta Neurochir (Wien)"},{"key":"1968_CR10","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s00066-005-1359-x","volume":"181","author":"S.E. Combs","year":"2005","unstructured":"Combs SE, Gutwein S, Schulz-Ertner D, et al. Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I\/II study. Strahlenther Onkol 2005;181:372\u20137.","journal-title":"Strahlenther Onkol"},{"key":"1968_CR11","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s00066-005-1415-6","volume":"181","author":"S.E. Combs","year":"2005","unstructured":"Combs SE, Gutwein S, Thilmann C, et al. Reirradiation of recurrent WHO grade III astrocytomas using fractionated stereotactic radiotherapy (FSRT). Strahlenther Onkol 2005;181:768\u201373.","journal-title":"Strahlenther Onkol"},{"key":"1968_CR12","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1002\/cncr.21429","volume":"104","author":"S.E. Combs","year":"2005","unstructured":"Combs SE, Widmer V, Thilmann C, et al. Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM). Cancer 2005;104:2168\u201373.","journal-title":"Cancer"},{"key":"1968_CR13","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/jnci\/85.9.704","volume":"85","author":"W.J. Curran Jr","year":"1993","unstructured":"Curran WJ Jr, Scott CB, Horton J, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993;85:704\u201310.","journal-title":"J Natl Cancer Inst"},{"key":"1968_CR14","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1056\/NEJMe058010","volume":"352","author":"L.M. DeAngelis","year":"2005","unstructured":"DeAngelis LM. Chemotherapy for brain tumors \u2014 a new beginning. N Engl J Med 2005;352:1036\u20138.","journal-title":"N Engl J Med"},{"key":"1968_CR15","volume-title":"Brachytherapy applications and techniques","author":"P.M. Devlin","year":"2007","unstructured":"Devlin PM. Brachytherapy applications and techniques. Philadelphia: Lippincott Williams & Wilkins, 2007."},{"key":"1968_CR16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11060-006-9231-0","volume":"81","author":"A. Ernst-Stecken","year":"2007","unstructured":"Ernst-Stecken A, Ganslandt O, Lambrecht U, et al. Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma. J Neurooncol 2007;81:287\u201394.","journal-title":"J Neurooncol"},{"key":"1968_CR17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00066-007-1673-6","volume":"183","author":"A.R. Fathi","year":"2007","unstructured":"Fathi AR, Vassella E, Arnold M, et al. Objective response to radiation therapy and long-term survival of patients with WHO grade II astrocytic gliomas with known LOH 1p\/19q status. Strahlenther Onkol 2007;183:517\u201322.","journal-title":"Strahlenther Onkol"},{"key":"1968_CR18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1227\/01.NEU.0000194836.07848.69","volume":"58","author":"A.J. Gabayan","year":"2006","unstructured":"Gabayan AJ, Green SB, Sanan A, et al. GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis. Neurosurgery 2006;58:701\u20139.","journal-title":"Neurosurgery"},{"key":"1968_CR19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1227\/00006123-198711000-00002","volume":"21","author":"G.R. Harsh","year":"1987","unstructured":"Harsh GR, Levin VA, Gutin PH, et al. Re-operation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery 1987;21:615\u201321.","journal-title":"Neurosurgery"},{"key":"1968_CR20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00066-008-1783-9","volume":"184","author":"B.A. Jereczek-Fossa","year":"2008","unstructured":"Jereczek-Fossa BA, Kowalczyk A, D\u2019Onofrio A, et al. Three-dimensional conformal or stereotactic reirradiation of recurrent, metastatic or new primary tumors. Analysis of 108 patients. Strahlenther Onkol 2008;184:36\u201340.","journal-title":"Strahlenther Onkol"},{"key":"1968_CR21","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ijrobp.2006.01.006","volume":"65","author":"J.A. Kalapurakal","year":"2006","unstructured":"Kalapurakal JA, Goldman S, Stellpflug W, et al. Phase I study of intraoperative radiotherapy with photon radiosurgery system in children with recurrent brain tumors: preliminary report of first dose level (10 Gy). Int J Radiat Oncol Biol Phys 2006;65:800\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1968_CR22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"E.L. Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457\u201381.","journal-title":"J Am Stat Assoc"},{"key":"1968_CR23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11060-006-9283-1","volume":"82","author":"K. Kohshi","year":"2007","unstructured":"Kohshi K, Yamamoto H, Nakahara A, et al. Fractionated stereotactic radiotherapy using gamma unit after hyperbaric oxygenation on recurrent high-grade gliomas. J Neurooncol 2007;82:297\u2013303.","journal-title":"J Neurooncol"},{"key":"1968_CR24","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0360-3016(02)03743-4","volume":"54","author":"D.A. Larson","year":"2002","unstructured":"Larson DA, Prados M, Lamborn KR, et al. Phase II study of high central dose gamma knife radiosurgery and marimastat in patients with recurrent malignant glioma. Int J Radiat Oncol Biol Phys 2002;54:1397\u2013404.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1968_CR25","first-page":"119","volume":"6","author":"D.A. Larson","year":"2004","unstructured":"Larson DA, Suplica JM, Chang SM, et al. Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme. Neurooncology 2004;6:119\u201326.","journal-title":"Neurooncology"},{"key":"1968_CR26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0360-3016(98)00266-1","volume":"43","author":"S.W. Lee","year":"1999","unstructured":"Lee SW, Fraass BA, Marsh LH, et al. Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study. Int J Radiat Oncol Biol Phys 1999;43:79\u201388.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1968_CR27","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/0360-3016(89)90518-X","volume":"17","author":"S.A. Leibel","year":"1989","unstructured":"Leibel SA, Gutin PH, Wara WM, et al. Survival and quality of life after interstitial implantation of removable high activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 1989;17:1129\u201339.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1968_CR28","first-page":"2100","volume-title":"Cancer: principles and practice of oncology","author":"V.A. Levin","year":"2001","unstructured":"Levin VA, Leibel SA, Gutin PH. Neoplasms of the central nervous system. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology, 6th edn. Philadelphia: Lippincott Williams & Wilkins, 2001:2100\u201360.","edition":"6"},{"key":"1968_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-2-1","volume":"2","author":"K. Nemoto","year":"2002","unstructured":"Nemoto K, Ogawa Y, Matsushita H, et al. Intraoperative radiation therapy (IORT) for previously untreated malignant gliomas. BMC Cancer 2002;2:1.","journal-title":"BMC Cancer"},{"key":"1968_CR30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000061231","volume":"33","author":"C. Nieder","year":"1999","unstructured":"Nieder C, Nestle U, Niewald M, et al. Hyperfractionated reirradiation for malignant glioma. Front Radiat Ther Oncol 1999;33:150\u20137.","journal-title":"Front Radiat Ther Oncol"},{"key":"1968_CR31","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/00006123-200005000-00019","volume":"46","author":"S. Patel","year":"2000","unstructured":"Patel S, Breneman JC, Warnik RE, et al. Permanent iodine 125 interstitial implants for the treatment of recurrent glioblastoma multiforme. Neurosurgery 2000;46:1123\u20138.","journal-title":"Neurosurgery"},{"key":"1968_CR32","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00066-007-1739-5","volume":"183","author":"M.D. Piroth","year":"2007","unstructured":"Piroth MD, Gagel B, Pinkawa M, et al. Postoperative radiotherapy of glioblastoma multiforme. Analysis and critical assessment of different treatment strategies and predictive factors. Strahlenther Onkol 2007;183:695\u2013702.","journal-title":"Strahlenther Onkol"},{"key":"1968_CR33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1200\/JCO.2005.03.4082","volume":"24","author":"D.A. Reardon","year":"2006","unstructured":"Reardon DA, Akabani G, Coleman RE, et al. Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results [Erratum in: J Clin Oncol 2006;24:1484]. J Clin Oncol 2006;24:115\u201322.","journal-title":"J Clin Oncol"},{"key":"1968_CR34","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s00066-005-1354-2","volume":"181","author":"P. Schueller","year":"2005","unstructured":"Schueller P, Micke O, Palkovic S, et al. 12 years\u2019 experience with intraoperative radiotherapy (IORT) of malignant gliomas. Strahlenther Onkol 2005;181:500\u20136.","journal-title":"Strahlenther Onkol"},{"key":"1968_CR35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0360-3016(99)00507-6","volume":"47","author":"E. Shaw","year":"2000","unstructured":"Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000;47:291\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1968_CR36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0360-3016(01)02804-8","volume":"53","author":"J.M. Simon","year":"2002","unstructured":"Simon JM, Cornu P, Boisserie G, et al. Brachytherapy of glioblastoma recurring in previously irradiated territory: predictive value of tumor volume. Int J Radiat Oncol Biol Phys 2002;53:67\u201374.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1968_CR37","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0360-3016(94)90559-2","volume":"29","author":"P.K. Sneed","year":"1994","unstructured":"Sneed PK, Gutin PH, Larson DA, et al. Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. Int J Radiat Oncol Biol Phys 1994;29:719\u201327.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1968_CR38","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R. Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987\u201396.","journal-title":"N Engl J Med"},{"key":"1968_CR39","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S1470-2045(05)70432-0","volume":"6","author":"M.J. Taphoorn","year":"2005","unstructured":"Taphoorn MJ, Stupp R, Coens C, et al. Health-related quality of life in patients with glioblastoma: a randomised controlled trial. Lancet Oncol 2005;6:937\u201344.","journal-title":"Lancet Oncol"},{"key":"1968_CR40","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00066-007-1759-1","volume":"183","author":"B. Timmermann","year":"2007","unstructured":"Timmermann B, Lomax AJ, Nobile L, et al. Novel technique of craniospinal axis proton therapy with the spot-scanning system. Avoidance of patching multiple fields and optimized ventral dose distribution. Strahlenther Onkol 2007;183:685\u20138.","journal-title":"Strahlenther Onkol"},{"key":"1968_CR41","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00066-007-1721-2","volume":"183","author":"N. Tselis","year":"2007","unstructured":"Tselis N, Kolotas C, Birn G, et al. CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results. Strahlenther Onkol 2007;183:563\u201370.","journal-title":"Strahlenther Onkol"},{"key":"1968_CR42","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00006123-199707000-00011","volume":"41","author":"S. Valtonen","year":"1997","unstructured":"Valtonen S, Timonen U, Toivanen P, et al. Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. Neurosurgery 1997;41:44\u20138, discussion 48-9.","journal-title":"Neurosurgery"},{"key":"1968_CR43","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0360-3016(99)00244-8","volume":"45","author":"G.M. Videtic","year":"1999","unstructured":"Videtic GM, Gaspar LE, Zamorano L, et al. Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas. Int J Radiat Oncol Biol Phys 1999;45:687\u201392.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1968_CR44","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/0360-3016(89)90941-3","volume":"16","author":"K.E. Wallner","year":"1989","unstructured":"Wallner KE, Galicich JH, Krol G, et al. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1989;16:1405\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-009-1968-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-009-1968-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-009-1968-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T02:30:54Z","timestamp":1558578654000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-009-1968-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["1968"],"URL":"https:\/\/doi.org\/10.1007\/s00066-009-1968-x","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}